Showing results (1591-1600 of 1,797) with videos related to
Sort By:
Pageof 180
Hepatology Communications|February 7, 2020
Magnetic Resonance Cholangiopancreatography Severity Predicts Disease Outcomes in Pediatric Primary Sclerosing Cholangitis: A Reliability and Validity StudyKedar Patil, Amanda Ricciuto, Alaa Alsharief, et al.Hepatology Communications|February 7, 2020
Targeting Liver Cancer Stem Cells Using Engineered Biological Nanoparticles for the Treatment of Hepatocellular CancerKaori Ishiguro, Irene K Yan, Laura Lewis-Tuffin, et al.Hepatology Communications|May 18, 2022
Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up studyNorio Akuta, Yusuke Kawamura, Shunichiro Fujiyama, et al.Hepatology Communications|May 24, 2022
Inhibition of nonhomologous end joining-mediated DNA repair enhances anti-HBV CRISPR therapyKazuhiro Murai, Takahiro Kodama, Hayato Hikita, et al.Hepatology Communications|July 19, 2021
Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver DiseaseAnuradha Ratna, Arlene Lim, Zihai Li, et al.Hepatology Communications|July 19, 2021
Type 2 Autoimmune Hepatitis and Nonadherence to Medication Correlate With Premature Birth and Risk of Postpartum FlareKathryn Olsen, James Hodson, Vincenzo Ronca, et al.Hepatology Communications|July 19, 2021
Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular FormationShinji Itoh, Tomoharu Yoshizumi, Yoshiyuki Kitamura, et al.Hepatology Communications|July 19, 2021
Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular CarcinomaMasashi Hirooka, Yohei Koizumi, Takaaki Tanaka, et al.Hepatology Communications|July 19, 2021
Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular CarcinomaKui Chen, Andre Gorgen, Avrilynn Ding, et al.Hepatology Communications|May 13, 2022
Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 proteinMichel A Struwe, Bernd Clement, Axel ScheidigPageof 180